If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRDL.L Regulatory News (RDL)

  • There is currently no data for RDL

Corporate Update

16 Sep 2016 07:00

RNS Number : 9978J
Ranger Direct Lending Fund PLC
16 September 2016
 

Ranger Direct Lending Fund PLC

(the "Company")

Corporate Update

 

The Company will be conducting investor meetings in the week beginning September 19th.

 

The Company announced last month that July marked the sixth consecutive month of achieving its investment target returns (70-80 bps per month unlevered). The Company's returns have also outperformed the Liberum AltFi Index by 104 bps over the 3 months to July 2016.

 

The Company is pleased to announce that the proceeds of August's successful ZDP offering are expected to be fully deployed during September. The performance of the Company's portfolio in August was in line with recent months when excluding the impact of the expenses associated with the ZDP offering. The Company expects a return to previous levels of investor returns for the month of September.

 

The Company continues to see growth and investment opportunities amongst its existing platforms and those in its due diligence pipeline. The Company has several platforms in the due diligence phase, the most advanced of which are two established lending businesses in secured medical lending and SME lending, respectively. In aggregate, the Company believes that there is substantial available deployment capacity amongst existing and new potential platforms for investments with net returns in line with its targets.

 

This document is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results.

 

For further information, please contact:

Capita Company Secretarial Services Limited +44 (0)20 7954 9531

Secretary

Ranger Capital Group

Bill Kassul via Redleaf PR 

Scott Canon

Liberum +44 (0)20 3100 2000

Simon Atkinson

Joshua Hughes

Media enquiries ranger@redleafpr.com

Redleaf Communications + 44 (0)20 7382 4731

Rebecca Sanders-Hewett

David Ison

Sam Modlin

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKNSFFKKEFF
Date   Source Headline
18th Jun 20187:30 amRNSBoard Changes
12th Jun 20183:09 pmRNSMonthly Update
12th Jun 20183:07 pmRNSNet Asset Value(s)
12th Jun 20187:00 amBUSOaktree Releases Open Letter to Shareholders: Changed Landscape Reinforces Need for Board Change
11th Jun 20183:35 pmRNSNotice of AGM
11th Jun 20187:00 amRNSManagement Review Process Update
8th Jun 20187:00 amBUSOaktree Releases Open Letter to Ranger Shareholders
6th Jun 20184:49 pmRNSResponse to Fourth Oaktree Letter
6th Jun 20187:11 amBUSOaktree Releases Open Letter to Ranger Shareholders
16th May 20184:31 pmRNSNotice of AGM
15th May 20182:46 pmRNSMonthly Update
15th May 20182:34 pmRNSNet Asset Value(s)
14th May 20183:51 pmRNSHolding(s) in Company
8th May 20187:00 amRNSResponse to Third Oaktree Letter
8th May 20187:00 amBUSOaktree Nominates Two Additional Directors for Upcoming Ranger Shareholder Annual General Meeting
4th May 20187:00 amBUSOaktree Releases an Open Letter to Ranger Shareholders following Proposal from RDL Board to Appoint Ares as Investment Manager
1st May 20187:47 amRNSManagement Review Update - Replacement
1st May 20187:18 amRNSManagement Review Update
30th Apr 20187:00 amRNSPortfolio Update
30th Apr 20187:00 amRNSAnnual Financial Report
27th Apr 201810:55 amRNSResponse to Second Oaktree Letter
27th Apr 20187:00 amBUSOaktree Sends Further Letter to Ranger Board of Directors
24th Apr 20182:58 pmRNSResponse to Oaktree
24th Apr 20181:54 pmBUSOaktree Sends Letter to Ranger Board of Directors Regarding Strategic Review
13th Apr 20182:43 pmRNSPortfolio Update
5th Apr 20184:40 pmRNSMonthly Update
5th Apr 20184:36 pmRNSNet Asset Value(s)
3rd Apr 20183:57 pmRNSHolding(s) in Company
3rd Apr 20183:56 pmRNSHolding(s) in Company
12th Mar 20187:48 amRNSPortfolio Update
6th Mar 20184:24 pmRNSMonthly Update
6th Mar 20184:20 pmRNSNet Asset Value(s)
1st Mar 20187:00 amRNSDividend Declaration
27th Feb 20183:06 pmRNSIFRS Implementation
23rd Feb 20182:49 pmRNSHolding(s) in Company
23rd Feb 20182:19 pmRNSHolding(s) in Company
6th Feb 20185:11 pmRNSMonthly Update
6th Feb 20185:09 pmRNSNet Asset Value(s)
6th Feb 20184:21 pmRNSHolding(s) in Company
29th Jan 20188:15 amRNSExternal Management & Princeton Arbitration Update
11th Jan 20184:43 pmRNSPortfolio Update
5th Jan 20183:47 pmRNSMonthly Update
5th Jan 20183:38 pmRNSNet Asset Value(s)
27th Dec 20173:44 pmRNSDirector/PDMR Shareholding
20th Dec 20174:22 pmRNSMonthly Update
20th Dec 20174:20 pmRNSNet Asset Value(s)
15th Dec 20173:38 pmRNSHolding(s) in Company
15th Dec 20177:00 amRNSPortfolio Update
14th Nov 20177:00 amRNSPrinceton - Portfolio Update
14th Nov 20177:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.